Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 2
2009 1
2014 2
2015 2
2016 3
2017 3
2018 3
2019 4
2020 5
2021 5
2022 8
2023 8
2024 6
2025 1
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
Enhancement of CD117-targeted bispecific T-cell engagement by CD33-targeted bispecific T-cell co-stimulation in acute myeloid leukemia.
Hofstetter M, Volta L, Koch C, Rey MG, Maurer M, Gönüllü N, Pellegrino C, Gobbi C, Schneiter F, Manfredi F, Magnani CF, Elsayed A, Schroeder T, Neri D, Manz MG. Hofstetter M, et al. Among authors: manfredi f. Cancer Res Commun. 2026 Mar 30. doi: 10.1158/2767-9764.CRC-25-0672. Online ahead of print. Cancer Res Commun. 2026. PMID: 41911066 Free article.
A single-chain variable fragment-based bispecific T-cell activating antibody against CD117 enables T-cell mediated lysis of acute myeloid leukemia and hematopoietic stem and progenitor cells.
Volta L, Myburgh R, Hofstetter M, Koch C, Kiefer JD, Gobbi C, Manfredi F, Zimmermann K, Kaufmann P, Fazio S, Pellegrino C, Russkamp NF, Villars D, Matasci M, Maurer M, Mueller J, Schneiter F, Büschl P, Harrer N, Mock J, Balabanov S, Nombela-Arrieta C, Schroeder T, Neri D, Manz MG. Volta L, et al. Among authors: manfredi f. Hemasphere. 2024 Nov 19;8(11):e70055. doi: 10.1002/hem3.70055. eCollection 2024 Nov. Hemasphere. 2024. PMID: 39564539 Free PMC article.
Extracellular vesicle-based anti-HOXB7 CD8+ T cell-specific vaccination strengthens antitumor effects induced by vaccination against Her2/neu.
Ferrantelli F, Manfredi F, Donnini M, Leone P, Pugliese K, Olivetta E, Giovannelli A, Di Virgilio A, Federico M, Chiozzini C. Ferrantelli F, et al. Among authors: manfredi f. Cancer Gene Ther. 2024 Nov;31(11):1688-1695. doi: 10.1038/s41417-024-00831-2. Epub 2024 Sep 19. Cancer Gene Ther. 2024. PMID: 39300218 Free PMC article.
Efficient combinatorial adaptor-mediated targeting of acute myeloid leukemia with CAR T-cells.
Volta L, Myburgh R, Pellegrino C, Koch C, Maurer M, Manfredi F, Hofstetter M, Kaiser A, Schneiter F, Müller J, Buehler MM, De Luca R, Favalli N, Magnani CF, Schroeder T, Neri D, Manz MG. Volta L, et al. Among authors: manfredi f. Leukemia. 2024 Dec;38(12):2598-2613. doi: 10.1038/s41375-024-02409-1. Epub 2024 Sep 18. Leukemia. 2024. PMID: 39294295 Free PMC article.
miR-92a-3p and miR-320a are Upregulated in Plasma Neuron-Derived Extracellular Vesicles of Patients with Frontotemporal Dementia.
Manzini V, Cappelletti P, Orefice NS, Brentari I, Rigby MJ, Lo Giudice M, Feligioni M, Rivabene R, Crestini A, Manfredi F, Talarico G, Bruno G, Corbo M, Puglielli L, Denti MA, Piscopo P. Manzini V, et al. Among authors: manfredi f. Mol Neurobiol. 2025 Feb;62(2):2573-2586. doi: 10.1007/s12035-024-04386-z. Epub 2024 Aug 14. Mol Neurobiol. 2025. PMID: 39138758 Free PMC article.
The longitudinal characterization of immune responses in COVID-19 patients reveals novel prognostic signatures for disease severity, patients' survival and long COVID.
Noviello M, De Lorenzo R, Chimienti R, Maugeri N, De Lalla C, Siracusano G, Lorè NI, Rancoita PMV, Cugnata F, Tassi E, Dispinseri S, Abbati D, Beretta V, Ruggiero E, Manfredi F, Merolla A, Cantarelli E, Tresoldi C, Pastori C, Caccia R, Sironi F, Marzinotto I, Saliu F, Ghezzi S, Lampasona V, Vicenzi E, Cinque P, Manfredi AA, Scarlatti G, Dellabona P, Lopalco L, Di Serio C, Malnati M, Ciceri F, Rovere-Querini P, Bonini C. Noviello M, et al. Among authors: manfredi f. Front Immunol. 2024 Jul 29;15:1381091. doi: 10.3389/fimmu.2024.1381091. eCollection 2024. Front Immunol. 2024. PMID: 39136010 Free PMC article.
TIM-3, LAG-3, or 2B4 gene disruptions increase the anti-tumor response of engineered T cells.
Cianciotti BC, Magnani ZI, Ugolini A, Camisa B, Merelli I, Vavassori V, Potenza A, Imparato A, Manfredi F, Abbati D, Perani L, Spinelli A, Shifrut E, Ciceri F, Vago L, Di Micco R, Naldini L, Genovese P, Ruggiero E, Bonini C. Cianciotti BC, et al. Among authors: manfredi f. Front Immunol. 2024 Feb 29;15:1315283. doi: 10.3389/fimmu.2024.1315283. eCollection 2024. Front Immunol. 2024. PMID: 38510235 Free PMC article.
Harnessing T cell exhaustion and trogocytosis to isolate patient-derived tumor-specific TCR.
Manfredi F, Stasi L, Buonanno S, Marzuttini F, Noviello M, Mastaglio S, Abbati D, Potenza A, Balestrieri C, Cianciotti BC, Tassi E, Feola S, Toffalori C, Punta M, Magnani Z, Camisa B, Tiziano E, Lupo-Stanghellini MT, Branca RM, Lehtiö J, Sikanen TM, Haapala MJ, Cerullo V, Casucci M, Vago L, Ciceri F, Bonini C, Ruggiero E. Manfredi F, et al. Sci Adv. 2023 Dec;9(48):eadg8014. doi: 10.1126/sciadv.adg8014. Epub 2023 Dec 1. Sci Adv. 2023. PMID: 38039364 Free PMC article.
52 results